EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Single-Dose Azithromycin for Ocular Chlamydial Infection: A Longitudinal Study

Neha Pondicherry, Amza Abdou, Boubacar Kadri, Beido Nassirou, Sun Y Cotter, Nicole E Varnado, Travis C Porco, Sheila K West, Thomas M Lietman, Jeremy D Keenan

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.23-0540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Neha Pondicherry und 9 weiteren Autor:innen. Beteiligte Einrichtung: Francis I. Proctor Foundation, University of California, San Francisco, California. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Trachoma, Chlamydia trachomatis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Millions of doses of azithromycin are distributed each year for trachoma, yet the treatment efficacy of a single dose of azithromycin for ocular Chlamydia infection has not been well characterized. In this study, four villages in Niger received a mass azithromycin distribution for trachoma. All 426 children aged 0–5 years residing in the study villages were offered conjunctival swabbing every 6 months to test for ocular Chlamydia trachomatis . Among the children infected with ocular Chlamydia before treatment, 6% (95% CI: 2–15%) tested positive for ocular Chlamydia infection 6 months later, and 15% (95% CI: 7–28%) tested positive 12 months later. The most important predictor of post-treatment ocular Chlamydia infection was pretreatment ocular Chlamydia infection (relative risk: 3.5, 95% CI: 1.3–9.4). Although the 6-monthly monitoring schedule was suboptimal for testing the treatment efficacy of an antibiotic, these findings are nonetheless consistent with high treatment efficacy of a single dose of azithromycin and suggest that additional interventions might be most effective if targeted to those children infected prior to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinAnti-Bacterial AgentsTrachomaChlamydia trachomatisHumansChild, PreschoolInfantFemaleMaleLongitudinal StudiesTreatment OutcomeChlamydia InfectionsNigerInfant, Newborn

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Francis I. Proctor Foundation, University of California, San Francisco, California.
  • Programme National de Santé Oculaire, Niamey, Niger.
  • Department of Ophthalmology, University of California, San Francisco, California.
  • Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland.
  • Department of Epidemiology & Biostatistics, University of California, San Francisco, California.
  • Institute for Global Health, University of California, San Francisco, California.

Zitieren

APA

Pondicherry, N., Abdou, A., Kadri, B., Nassirou, B., Cotter, S. Y., Varnado, N. E., Porco, T. C., West, S. K., Lietman, T. M., & Keenan, J. D. (2024). Efficacy of Single-Dose Azithromycin for Ocular Chlamydial Infection: A Longitudinal Study. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0540

Vancouver

Pondicherry N, Abdou A, Kadri B, Nassirou B, Cotter SY, Varnado NE, et al. Efficacy of Single-Dose Azithromycin for Ocular Chlamydial Infection: A Longitudinal Study. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0540

BibTeX
@article{Pondicherry2024,
  author = {Pondicherry, Neha and Abdou, Amza and Kadri, Boubacar and Nassirou, Beido and Cotter, Sun Y and Varnado, Nicole E and Porco, Travis C and West, Sheila K and Lietman, Thomas M and Keenan, Jeremy D},
  title = {Efficacy of Single-Dose Azithromycin for Ocular Chlamydial Infection: A Longitudinal Study},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.23-0540}
}
Kostenlos starten →